Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Everest Medicines launches 2030 Strategy to accelerate Asia-focused biopharma growth and global R&D globalization
Monday, December 15, 2025Everest Medicines has launched its Strategy outlining a fiveyear roadmap to expand its innovative therapeutics pipeline scale its commercial portfolio across Asian markets and globalize RD and commercialization capabilities while directors and a maj...
Fosun Pharma Signs International Licence Agreements with Pfizer and Sitala to Expand Global Biopharma Footprint
Friday, December 12, 2025Fosun Pharma has entered into international licence agreements with Pfizer and Sitala strengthening its global biopharma pipeline and crossborder commercialization strategy
Cloudbreak Pharma Strengthens Asia-Focused Ophthalmology Pipeline and Global Commercialisation Prospects with New Patents and Clinical Milestones
Thursday, December 11, 2025Cloudbreak Pharma has secured new patents in Japan and Europe for its lead ophthalmic candidate CBT and reported positive Phase data for CBT reinforcing its Asiacentered ophthalmology portfolio and positioning the company for future global partnerin...
Telix and Varian Collaboration to Combine Theranostics with EBRT
Thursday, December 11, 2025Telix has announced a new clinical collaboration with Varian The partnership aims to develop new clinical approaches that bring together Telixs theranostic products with external beam radiation therapy EBRT
Beren Therapeutics Receives Breakthrough Therapy Designation for Investigational Drug Adrabetadex for Infantile-Onset Niemann-Pick Disease Type C
Thursday, December 11, 2025Beren Therapeutics has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation BTD to adrabetadex an investigational treatment for infantileonset NiemannPick disease type C NPC
Boehringer Ingelheim’s JASCAYD® (nerandomilast) Receives Approval for Progressive Pulmonary Fibrosis
Thursday, December 11, 2025Boehringer Ingelheim has received approval from Chinas National Medical Products Administration NMPA for JASCAYD nerandomilast marking the first new treatment for adults with progressive pulmonary fibrosis PPF in more than five years
Ajax Therapeutics Receives Orphan Drug Designation for Myelofibrosis Candidate
Thursday, December 11, 2025Ajax Therapeutics has received Orphan Drug Designation from the US Food and Drug Administration for AJ a nextgeneration JAK inhibitor being developed for myelofibrosis AJ was created through structurebased drug design and advanced computational meth...
Fosun Pharma’s Yao Pharma signs US$2.1 billion global licensing deal with Pfizer for oral GLP-1 obesity drug candidate YP05002
Wednesday, December 10, 2025Fosun Pharmas subsidiary Yao Pharma has entered a global licensing agreement worth up to US billion with Pfizer for its oral GLP receptor agonist obesity candidate YP advancing Chinaorigin metabolic innovation onto the global stage
Amneal Received Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals
Wednesday, December 10, 2025Amneal Pharmaceuticals has received approval from the US Food and Drug Administration FDA for its epinephrine injection USP mgmL in both singledose mL and multidose mL vials
Formycon and Zydus Agreement for FYB206, a Biosimilar to Keytruda®
Wednesday, December 10, 2025Formycon AG and Zydus Lifesciences have entered a strategic partnership for the exclusive licensing and supply of FYB a biosimilar version of pembrolizumab for the US and Canadian markets
